{"id":"W4310786296","doi":"10.1111/bjh.18582","title":"Fostamatinib for the treatment of Japanese patients with primary immune thrombocytopenia: A phase 3, placebo‐controlled, double‐blind, parallel‐group study","year":2022,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"","keywords":"Medicine; Placebo; Syk; Immune thrombocytopenia; Adverse effect; Internal medicine; Placebo group; Gastroenterology; Double blind; Platelet; Tyrosine kinase; Receptor; Pathology","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001762103,0.001114649,0.003240587,0.0002482625,0.0004707026,0.0006412966,0.0005500648,0.0009933122,0.002032377],"category_scores_gemma":[0.0009932776,0.0004179958,0.001861862,0.000453774,0.0009411501,0.0005759894,0.0002318853,0.001403353,0.0002944244],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006867207,"about_ca_system_score_gemma":0.001721665,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001459445,"about_ca_topic_score_gemma":0.004095715,"domain_scores_codex":[0.9994162,0.0002557776,0.00006019722,0.00009429995,0.00008031193,0.00009319927],"domain_scores_gemma":[0.9993916,0.00007812806,0.0001312629,0.00004962051,0.00007880003,0.0002706945],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.8969975,0.01533777,0.00318575,0.002464998,0.003113597,0.0002656861,0.0003147353,0.0004849057,0.02284968,0.000127872,0.001345486,0.05351213],"study_design_scores_gemma":[0.7938682,0.1884426,0.01275014,0.00003756517,0.001590114,0.0002101984,0.00006222852,0.0003769117,0.001159051,0.00007751054,0.001394591,0.00003103209],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9915761,0.005012883,0.000352839,0.0003229211,0.0001595165,0.001513822,0.0002828365,0.00003314064,0.0007459394],"genre_scores_gemma":[0.9924638,0.003275361,0.0008343585,0.0006468985,0.0002138908,0.001459606,0.0003976656,0.000008028478,0.0007004543],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003240587,"threshold_uncertainty_score":0.009319007,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02356153659679367,"score_gpt":0.2988072891600148,"score_spread":0.2752457525632211,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}